Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Igor Koralnik is a Neurologist in Chicago, Illinois. Koralnik has been practicing medicine for over 36 years and is rated as an Elite expert by MediFind in the treatment of CACH Syndrome. He is also highly rated in 16 other conditions, according to our data. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, CACH Syndrome, Encephalitis, Tuberculous Meningitis, and Endovascular Embolization. Koralnik is currently accepting new patients.
Florian Eichler is a Neurologist in Boston, Massachusetts. Eichler has been practicing medicine for over 26 years and is rated as an Elite expert by MediFind in the treatment of CACH Syndrome. He is also highly rated in 24 other conditions, according to our data. His top areas of expertise are CACH Syndrome, Adrenoleukodystrophy (ALD), Leukodystrophy, and Hereditary Sensory Neuropathy Type 1 (HSN1). Eichler is currently accepting new patients.
Adeline Vanderver is a Neurologist and a Child Neurologist in Philadelphia, Pennsylvania. Vanderver has been practicing medicine for over 25 years and is rated as an Elite expert by MediFind in the treatment of CACH Syndrome. She is also highly rated in 23 other conditions, according to our data. Her top areas of expertise are Leukodystrophy, Aicardi-Goutieres Syndrome, CACH Syndrome, and Pol 3-Related Leukodystrophy. Vanderver is currently accepting new patients.
Summary: Central Nervous System (CNS) demyelinating conditions include multiple sclerosis (MS), Acute Disseminated Encephalomyelitis (ADEM), Neuromyelitis Optica Spectrum Disorder (NMOSD), Optic Neuritis (ON) and Transverse Myelitis (TM). The symptoms of these conditions are quite variable from patient to patient, but can include motor, sensory, visual, gait and cognitive changes. Conventional MRI can be u...
Summary: A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts: Part A - first in human study in which patients receive a single dose of ANK-700 Part B - patients will receive three doses of either ANK-700 or placebo